
Patient stratification autoimmune trials remains challenge
Excelra’s AI-driven multi-omics analytics enables precise subgroup identification: na2.hubs.ly/H04kKSj0
ML on integrated omics revealed 21 predictive biomarkers
#DrugDiscovery #Excelra

Français
















